Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.

Ann Transplant · 2026 · PMC13032489 · PMID 41873018

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

showed a trendP =0.071so close (0.05 < p ≤ 0.1)

Concurrent steroid use was associated with fewer immune-related adverse events (0% vs 30%, P =0.052) but showed a trend toward shorter PFS (HR=2.30, P =0.071).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.